HealthEquity (HQY) revenue breakdown
By product, Custodial is the largest at 48% of fiscal 2026 revenue, growing 30% a year over 9 years.
Revenue by product
Fiscal years, as HealthEquity reports them in its 10-K filings; fiscal 2026 total $1.3B.
| Products | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Custodial | $60M | $87M | $126M | $182M | $191M | $186M | $261M | $387M | $545M | $637M | 48% |
| Service | $77M | $92M | $101M | $263M | $431M | $444M | $452M | $456M | $478M | $485M | 37% |
| Interchange | $42M | $51M | $61M | $87M | $112M | $127M | $148M | $157M | $176M | $192M | 15% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for HQY.
Open HQY in InvestinglyQuestions
Where does HealthEquity make its money?
In fiscal 2026, by product: Custodial $637M, Service $485M, Interchange $192M.
From HealthEquity's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.